Octreotide, a somatostatin analogue, attenuates movement evoked discharges of fine afferent units from inflamed knee joints of rats

Neuroscience Letters

Volumn 361, Issue 1-3, 2004, Pages 180-183

  Pawlak, Matthias ^a   Schmidt, Robert F ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Arthritis; Articular pain; Cyclo somatostatin; Nociception

Indexed keywords

OCTREOTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ELECTROPHYSIOLOGY; EVOKED MUSCLE RESPONSE; KNEE ARTHRITIS; MALE; MECHANOTRANSDUCTION; NONHUMAN; PRIORITY JOURNAL; RAT; SENSORY NERVE CELL; SPIKE WAVE;

ACTION POTENTIALS; ANIMALS; ARTHRALGIA; ARTHRITIS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; KNEE JOINT; MALE; MOVEMENT; NEURONS, AFFERENT; NOCICEPTORS; OCTREOTIDE; PEPTIDES, CYCLIC; RANGE OF MOTION, ARTICULAR; RATS; RATS, WISTAR; RECEPTORS, SENSORY; SOMATOSTATIN;

EID: 2342590681     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2003.12.021     Document Type: Article

References (18)

1. Betoin F., Advenier C., Fardin V., Wilcox G., Lavarenne J., Eschalier A. In vitro and in vivo evidence for a tachykinin NK1 receptor antagonist effect of vapreotide, an analgesic cyclic analog of somatostatin. Eur. J. Pharmacol. 279:1995;241-249
2. Bjorling D.E., Saban M.R., Saban R. Effect of octreotide, a somatostatin analogue, on release of inflammatory mediators from isolated guinea pig bladder. J. Urol. 158:1997;258-264
3. Carlton S.M., Du J., Davidson E., Zhou S., Coggeshall R.E. Somatostatin receptors on peripheral primary afferent terminals: inhibition of sensitized nociceptors. Pain. 90:2001;233-244
4. Carlton S.M., Du J., Zhou S., Coggeshall R.E. Tonic control of peripheral cutaneous nociceptors by somatostatin receptors. J. Neurosci. 21:2001;4042-4049
5. Elhassan A.M., Adem A., Hultenby K., Lindgren J.U. Somatostatin immunoreactivity in bone and joint tissues. NeuroReport. 9:1998;2573-2575
6. Fioravanti A., Govoni M., La Montagna G., Perpignano G., Tirri G., Trotta F., Bogliolo A., Ciocci A., Mauceri M.T., Marcolongo R. Somatostatin 14 and joint inflammation: evidence for intraarticular efficacy of prolonged administration in rheumatoid arthritis. Drugs Exp. Clin. Res. 21:1995;97-103
7. Hanesch U., Heppelmann B., Schmidt R.F. Somatostatin-like immunoreactivity in primary afferents of the medial articular nerve and colocalization with substance P in the cat. J. Comp. Neurol. 354:1995;345-352
8. Helyes Z., Pinter E., Nemeth J., Keri G., Than M., Oroszi G., Horvath A., Szolcsanyi J. Anti-inflammatory effect of synthetic somatostatin analogues in the rat. Br. J. Pharmacol. 134:2001;1571-1579
9. Heppelmann B., Pawlak M. Inhibitory effect of somatostatin on the mechanosensitivity of articular afferents in normal and inflamed knee joints of the rat. Pain. 73:1997;377-382
10. Heppelmann B., Pawlak M. Peripheral application of cyclo-somatostatin, a somatostatin antagonist, increases the mechanosensitivity of rat knee joint afferents. Neurosci. Lett. 259:1999;62-64
11. Just S., Pawlak M., Heppelmann B. Responses of fine primary afferent nerve fibres innervating the rat knee joint to defined torque. J. Neurosci. Methods. 103:2000;157-162
12. Kapicioglu S., Gökce E., Kapicioglu Z., Ovali E. Treatment of migraine attack with a long-acting somatostatin analogue (octreotide, SMS 201-995). Cephalalgia. 17:1997;27-30
13. Kurnatowska I., Pawlikowski M. Anti-inflammatory effects of somatostatin analogs on zymosan-induced earlobe inflammation in mice: comparison with dexamethasone and ketoprofen. Neuroimmunomodulation. 9:2001;119-124
14. Malcangio M. GDNF and somatostatin in sensory neurons. Curr. Opin. Pharmacol. 3:2003;41-45
15. Paran D., Elkayam O., Mayo H., Paran H., Amit M., Yaron M., Caspi D. A pilot study of a long acting somatostatin analogue for the treatment of refractory rheumatoid arthritis. Ann. Rheum. Dis. 60:2001;888-891
16. Pawlak M., Messlinger K., Zehnter A., Schmidt R.F. Somatostatin reduces the meningeal arterial blood flow in the rat. Neurosci. Lett. 276:1999;33-36
17. Schmidt R.F., Schaible H.-G., Meßlinger K., Heppelmann B., Hanesch U., Pawlak M. Silent and active nociceptors: structure, functions and clinical implications. Gebhart D.L., Hammond D.L., Jensen T.S. Progress in Pain Research and Management. 2:1994;213-250 IASP Press, Seattle, WA
18. Traub R.J., Brzoski D. Anti-somatostatin antisera, but neither a somatostatin agonist (octreotide) nor antagonist (CYCAM), attenuates hyperalgesia in the rat. Peptides. 17:1996;769-773